CORCEPT THERAPEUTICS INC
CORT
DELAYED 1 MONTH
34 insider filings · Latest: Jun 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Jun 4 8:49 PM | William GuyerChief Development Officer | Sale | 20,000 | $70.60 | $1.4M | 3,985(D) | View → |
| Jun 1, 2026 | Jun 3 11:20 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 25,000 | $70.21 | $1.8M | 8,977(D) | View → |
| Jun 1, 2026 | Jun 3 11:20 PM | Atabak MokariChief Financial Officer | Sale | 40,000 | $70.00 | $2.8M | 15,257(D) | View → |
| Jun 1, 2026 | Jun 2 8:05 PM | BELANOFF JOSEPH KDirector, Chief Executive Officer | Sale | 12,837 | $69.74 | $895.3K | 2,565,489(I) | View → |
| May 27, 2026 | May 29 10:11 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Sale | 5,000 | $65.00 | $325.0K | 6,230(D) | View → |
| May 27, 2026 | May 29 10:03 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 75,000 | $65.59 | $4.9M | 8,977(D) | View → |
| May 5, 2026 | May 7 8:30 PM | William GuyerChief Development Officer | Sale | 20,000 | $51.83 | $1.0M | 2,231(D) | View → |
| May 1, 2026 | May 5 8:30 PM | BELANOFF JOSEPH KDirector, Chief Executive Officer | Sale | 40,000 | $50.10 | $2.0M | 2,878,326(I) | View → |
| Mar 4, 2026 | Mar 6 9:30 PM | William GuyerChief Development Officer | Sale | 8,233 | $35.99 | $296.3K | 2,231(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Jun 4 8:49 PM | William GuyerChief Development Officer | Option Exercise | 20,000 | $21.65 | 150,000(D) | View → |
| Jun 1, 2026 | Jun 3 11:20 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 25,000 | $8.27 | 141,986(D) | View → |
| Jun 1, 2026 | Jun 3 11:20 PM | Atabak MokariChief Financial Officer | Option Exercise | 40,000 | $19.26 | 60,000(D) | View → |
| May 27, 2026 | May 29 10:03 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 75,000 | $8.27 | 166,986(D) | View → |
| May 21, 2026 | May 26 9:40 PM | BAKER G LEONARD JRDirector | Grant/Award | 12,500 | $59.69 | 12,500(D) | View → |
| May 21, 2026 | May 26 9:39 PM | Gregg H AltonDirector | Grant/Award | 12,500 | $59.69 | 12,500(D) | View → |
| May 21, 2026 | May 26 9:36 PM | James N WilsonDirector | Grant/Award | 12,500 | $59.69 | 12,500(D) | View → |
| May 21, 2026 | May 26 9:35 PM | Daniel N Swisher JRDirector | Grant/Award | 12,500 | $59.69 | 12,500(D) | View → |
| May 21, 2026 | May 26 9:33 PM | Joshua M. MurrayDirector | Grant/Award | 12,500 | $59.69 | 12,500(D) | View → |
| May 21, 2026 | May 26 9:31 PM | David L MahoneyDirector | Grant/Award | 12,500 | $59.69 | 12,500(D) | View → |
| May 21, 2026 | May 26 9:28 PM | Kimberly ParkDirector | Grant/Award | 12,500 | $59.69 | 12,500(D) | View → |
| May 5, 2026 | May 7 8:30 PM | William GuyerChief Development Officer | Option Exercise | 20,000 | $21.65 | 170,000(D) | View → |
| Mar 4, 2026 | Mar 6 9:30 PM | William GuyerChief Development Officer | Option Exercise | 8,233 | $21.65 | 221,767(D) | View → |
| Feb 27, 2026 | Mar 3 11:19 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:17 PM | BELANOFF JOSEPH KDirector, Chief Executive Officer | Grant/Award | 460,000 | $35.70 | 460,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:16 PM | Atabak MokariChief Financial Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:14 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:14 PM | Hazel HuntChief Scientific Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:13 PM | Gary Charles RobbChief Business Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |
| Feb 27, 2026 | Mar 3 11:13 PM | William GuyerChief Development Officer | Grant/Award | 140,000 | $35.70 | 140,000(D) | View → |